Wird geladen...
Current targeted therapeutics against COVID-19: Based on first-line experience in China
SARS-CoV-2 is a novel strain, causing a global pandemic since the end of 2019. The majority of patients showed nonspecific symptoms such as fever, dry cough, and fatigue. Most patients have a good prognosis while some with severe conditions could rapidly progress to acute respiratory distress syndro...
Gespeichert in:
| Veröffentlicht in: | Pharmacol Res |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Ltd.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7192075/ https://ncbi.nlm.nih.gov/pubmed/32360585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104854 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|